[Medical treatment of Raynaud's syndrome]
- PMID: 3065874
- DOI: 10.1016/s0248-8663(88)80148-6
[Medical treatment of Raynaud's syndrome]
Abstract
The authors review the drug treatment of Raynaud's disease. Many substances have been used including nitrate derivatives, calcium antagonists, alpha blockers, angiotensin converting enzyme inhibitors, prostaglandin E1, E2 and I2, and ketanserin. The efficacy of these drugs is often partial and variable. The indications are discussed with respect to the clinical course and etiology of the Raynaud's phenomenon.
Similar articles
-
[Treatment of Raynaud's syndrome in systemic connective tissue diseases with calcium antagonists].Vutr Boles. 1988;27(6):55-8. Vutr Boles. 1988. PMID: 3247706 Bulgarian.
-
Pharmacotherapy of Raynaud's phenomenon.Drugs. 1996 Nov;52(5):682-95. doi: 10.2165/00003495-199652050-00006. Drugs. 1996. PMID: 9118818 Review.
-
[Raynaud's disease and Raynaud's phenomenon in connective tissue diseases].Pol Arch Med Wewn. 2002 Oct;108(4):1011-22. Pol Arch Med Wewn. 2002. PMID: 12642947 Review. Polish. No abstract available.
-
The role of endothelin-1 and selected cytokines in the pathogenesis of Raynaud's phenomenon associated with systemic connective tissue diseases.Int Angiol. 2006 Jun;25(2):221-7. Int Angiol. 2006. PMID: 16763543
-
[Raynaud's phenomenon in children].Arch Pediatr. 2004 Jan;11(1):74-7. doi: 10.1016/j.arcped.2003.09.030. Arch Pediatr. 2004. PMID: 14700771 Review. French.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical